NonprofitsCure Als

Medical Research

Cure Als

IRVING, TX

Total revenue

$21K

Total expenses

$21K

Net assets

$6K

Grants received

$85K

9 grants

EIN

273069910

Tax year

2024

Mission

CURE ALS' primary exempt purpose is to raise funds for ALS research.

Financials

FY 2024

Revenue

Contributions & grants$21K
Program service revenue
Investment income
Other revenue
Total revenue$21K

Expenses

Grants paid$21K
Salaries & benefits
Fundraising
Other expenses$222
Total expenses$21K
Total assets$6K
Net assets$6K

People

5 listed

NameRoleCompensation

Frank Stanesic

Chairman

Board

1 hrs/wk

Susan Dillon

Board Member

Board

1 hrs/wk

Kathy Tavano

Board Member and Treasurer

Board

3 hrs/wk

Hollis Roberts

Secretary

Board

1 hrs/wk

Paul Tavano

President

Board

2 hrs/wk

Grants received

Showing 9 of 9

FromAmountPurposeYear
$1K
GENERAL FUND
2024
$12K
GENERAL SUPPORT
2022
$54
EMPLOYEE MATCHING GIFT DONATION
2022
$7K
Unrestricted
2018
$780
Matching Grant
2018

Funded by

$85K from 6 funders · 9 grants · 2018–2024

American Online Giving Foundation Inc

$65K · 4 grants · 2021–2024

The Blackbaud Giving Fund

$12K · 1 grant · 2022

Network For Good

$7K · 1 grant · 2018

Maibach Family Foundation

$1K · 1 grant · 2024

AbbVie Foundation

$780 · 1 grant · 2018

Duke Energy Foundation

$54 · 1 grant · 2022

Details

EIN273069910
NTEE codeH12
Subsection03
Ruling date2010-11
CURE ALS — Mission, Financials & Grants Received | Grantivo